Integrated 18F-T807 Tau PET, Structural MRI, and Plasma Tau in Tauopathy Neurodegenerative Disorders

Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration

(2020) Elisabeth H. Thijssen et al.   NATURE MEDICINE

Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts

(2020) Thomas K Karikari et al.   LANCET NEUROLOGY

Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes

(2020) Adam S. Fleisher et al.   JAMA Neurology

Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer’s disease

(2020) Nicolas R. Barthélemy et al.   JOURNAL OF EXPERIMENTAL MEDICINE

First Tau PET Tracer Approved: Toward Accurate In Vivo Diagnosis of Alzheimer Disease

(2020) Henryk Barthel   JOURNAL OF NUCLEAR MEDICINE

Tau PET imaging in neurodegenerative tauopathies—still a challenge

(2019) Antoine Leuzy et al.   MOLECULAR PSYCHIATRY

18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes

(2019) Richard M. Tsai et al.   Alzheimers Research & Therapy

New and Old TSPO PET Radioligands for Imaging Brain Microglial Activation in Neurodegenerative Disease

(2019) Laura Best et al.   Current Neurology and Neuroscience Reports

Tau Imaging in Neurodegenerative Diseases Using Positron Emission Tomography

(2019) Yi Ting Wang et al.   Current Neurology and Neuroscience Reports

Multimodal neuroimaging relationships in progressive supranuclear palsy

(2019) Irene Sintini et al.   PARKINSONISM & RELATED DISORDERS

An one-pot two-step automated synthesis of [18F]T807 injection, its biodistribution in mice and monkeys, and a preliminary study in humans

(2019) Ya-Yao Huang et al.   PLoS One

Blood NfL

(2019) Chin-Hsien Lin et al.   NEUROLOGY

18F-AV1451 PET imaging and multimodal MRI changes in progressive supranuclear palsy

(2019) Nicolas Nicastro et al.   JOURNAL OF NEUROLOGY

Binding of [18F]AV1451 in post mortem brain slices of semantic variant primary progressive aphasia patients

(2019) Jolien Schaeverbeke et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography

(2018) Michelle M. Mielke et al.   Alzheimers & Dementia

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

(2018) Clifford R. Jack et al.   Alzheimers & Dementia

Plasma Biomarkers Differentiate Parkinson’s Disease From Atypical Parkinsonism Syndromes

(2018) Chin-Hsien Lin et al.   Frontiers in Aging Neuroscience

Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?

(2018) Cyril Laurent et al.   Biomedical Journal

Disease-related patterns of in vivo pathology in Corticobasal syndrome

(2018) Flavia Niccolini et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Regional times to equilibria and their impact on semi-quantification of [18F]AV-1451 uptake

(2018) Kerstin Heurling et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

The Role of Tau Imaging in Parkinsonian Disorders

(2018) Jochen Hammes et al.   Current Neurology and Neuroscience Reports

Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria

(2017) Günter U. Höglinger et al.   MOVEMENT DISORDERS

PETPVE12: an SPM toolbox for Partial Volume Effects correction in brain PET – Application to amyloid imaging with AV45-PET

(2017) Gabriel Gonzalez-Escamilla et al.   NEUROIMAGE

Serum neurofilament light in familial Alzheimer disease

(2017) Philip S.J. Weston et al.   NEUROLOGY

18 F-AV-1451 binds to motor-related subcortical gray and white matter in corticobasal syndrome

(2017) Hanna Cho et al.   NEUROLOGY

In vivo retention of 18 F-AV-1451 in corticobasal syndrome

(2017) Ruben Smith et al.   NEUROLOGY

[18F]AV-1451 tau-PET uptake does correlate with quantitatively measured 4R-tau burden in autopsy-confirmed corticobasal degeneration

(2016) Keith A. Josephs et al.   ACTA NEUROPATHOLOGICA

In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum

(2016) Hanna Cho et al.   ANNALS OF NEUROLOGY

Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer’s disease

(2016) Rik Ossenkoppele et al.   BRAIN

Positron emission tomography imaging of tau pathology in progressive supranuclear palsy

(2016) Sarah Coakeley et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Pharmacokinetic Evaluation of the Tau PET Radiotracer 18 F-T807 ( 18 F-AV-1451) in Human Subjects

(2016) Dustin W. Wooten et al.   JOURNAL OF NUCLEAR MEDICINE

[18F]AV-1451 tau positron emission tomography in progressive supranuclear palsy

(2016) Jennifer L. Whitwell et al.   MOVEMENT DISORDERS

Subcortical18F-AV-1451 binding patterns in progressive supranuclear palsy

(2016) Hanna Cho et al.   MOVEMENT DISORDERS

Increased basal ganglia binding of18F-AV-1451 in patients with progressive supranuclear palsy

(2016) Ruben Smith et al.   MOVEMENT DISORDERS

How neuroinflammation contributes to neurodegeneration

(2016) R. M. Ransohoff   SCIENCE

An autoradiographic evaluation of AV-1451 Tau PET in dementia

(2016) Val J. Lowe et al.   Acta Neuropathologica Communications

Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue

(2015) Marta Marquié et al.   ANNALS OF NEUROLOGY

Tau in physiology and pathology

(2015) Yipeng Wang et al.   NATURE REVIEWS NEUROSCIENCE

Non-invasive assessment of Alzheimer’s disease neurofibrillary pathology using 18F-THK5105 PET

(2014) Nobuyuki Okamura et al.   BRAIN

Tau PET Imaging in Alzheimer’s Disease

(2014) Nobuyuki Okamura et al.   Current Neurology and Neuroscience Reports

Clinicopathologic assessment and imaging of tauopathies in neurodegenerative dementias

(2014) Melissa E Murray et al.   Alzheimers Research & Therapy

Criteria for the diagnosis of corticobasal degeneration

(2013) M. J. Armstrong et al.   NEUROLOGY

The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Guy M. McKhann et al.   Alzheimers & Dementia

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia

(2011) Katya Rascovsky et al.   BRAIN

Classification of primary progressive aphasia and its variants

(2011) M. L. Gorno-Tempini et al.   NEUROLOGY

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results

(2008) Christopher G. Goetz et al.   MOVEMENT DISORDERS